Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 18317301)

1.

Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.

Teo BK, Badiee S, Hadi M, Lam T, Johnson L, Seo Y, Bacharach SL, Hasegawa BH, Franc BL.

Nucl Med Commun. 2008 Apr;29(4):359-66. doi: 10.1097/MNM.0b013e3282f44f99.

PMID:
18317301
2.

Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.

Shammas A, Lim R, Charron M.

Radiographics. 2009 Sep-Oct;29(5):1467-86. doi: 10.1148/rg.295085247. Review.

PMID:
19755606
3.

18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.

Braun JJ, Kessler R, Constantinesco A, Imperiale A.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1537-43. doi: 10.1007/s00259-008-0770-9. Epub 2008 Apr 17. Review.

PMID:
18418595
4.

The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective.

Lucignani G, Paganelli G, Bombardieri E.

Nucl Med Commun. 2004 Jul;25(7):651-6. Review.

PMID:
15208491
5.

Usefulness of FDG PET for diagnosis and radiotherapy of the patient with malignant lymphoma involving bone marrow.

Nihashi T, Hayasaka K, Itou T, Sobajima T, Kato R, Ito K, Ito Y, Ishigaki T, Naganawa S.

Radiat Med. 2007 Apr;25(3):130-4. Epub 2007 Apr 27. Review.

PMID:
17450338
6.

18F FDG-PET imaging in musculoskeletal infection.

Stumpe KD, Strobel K.

Q J Nucl Med Mol Imaging. 2006 Jun;50(2):131-42. Review.

7.

Quantification in clinical fluorodeoxyglucose positron emission tomography.

Hallett WA.

Nucl Med Commun. 2004 Jul;25(7):647-50. Review.

PMID:
15208490
8.

A systematic review of the factors affecting accuracy of SUV measurements.

Adams MC, Turkington TG, Wilson JM, Wong TZ.

AJR Am J Roentgenol. 2010 Aug;195(2):310-20. doi: 10.2214/AJR.10.4923. Review. Erratum in: AJR Am J Roentgenol. 2010 Oct;195(4):1043.

PMID:
20651185
9.

Need for standardization of 18F-FDG PET/CT for treatment response assessments.

Boellaard R.

J Nucl Med. 2011 Dec;52 Suppl 2:93S-100S. doi: 10.2967/jnumed.110.085662. Review.

10.

Structural and functional imaging of normal bone marrow and evaluation of its age-related changes.

Blebea JS, Houseni M, Torigian DA, Fan C, Mavi A, Zhuge Y, Iwanaga T, Mishra S, Udupa J, Zhuang J, Gopal R, Alavi A.

Semin Nucl Med. 2007 May;37(3):185-94. Review.

PMID:
17418151
11.

Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.

Mayer D, Bednarczyk EM.

Ann Pharmacother. 2002 Nov;36(11):1796-9. Review.

PMID:
12398579
12.

Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy.

Kinahan PE, Fletcher JW.

Semin Ultrasound CT MR. 2010 Dec;31(6):496-505. doi: 10.1053/j.sult.2010.10.001. Review.

13.

Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.

Chicklore S, Goh V, Siddique M, Roy A, Marsden PK, Cook GJ.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):133-40. doi: 10.1007/s00259-012-2247-0. Epub 2012 Oct 13. Review.

PMID:
23064544
14.

PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.

Tomasi G, Rosso L.

Curr Opin Pharmacol. 2012 Oct;12(5):569-75. doi: 10.1016/j.coph.2012.07.016. Epub 2012 Aug 15. Review.

PMID:
22901680
15.

Image quality with non-standard nuclides in PET.

Laforest R, Liu X.

Q J Nucl Med Mol Imaging. 2008 Jun;52(2):151-8. Epub 2007 Nov 28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk